Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys. Reframing the debate on prenatal HIV testing.
Minkoff
H
H
Department of Obstetrics and Gynecology, State University of New York Health Science Center at Brooklyn 11203, USA.
Willoughby
A
A
D015492:AIDS Serodiagnosis / Q000331:legislation & jurisprudence*; D035041:Anonymous Testing; D000998:Antiviral Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000151:congenital / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D007258:Informed Consent / Q000331:legislation & jurisprudence; D018580:Mandatory Testing / Q000331:legislation & jurisprudence*; D010344:Patient Advocacy / Q000331:legislation & jurisprudence; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000517:prevention & control*; D037841:Pregnant People; D018570:Risk Assessment; D014481:United States; D035141:Voluntary Programs; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine